Endocrine therapy

Endocrine therapy has been studied in 38 papers since 2016: 24 observational studies in people, 14 reviews; 19 in the past year. The newest story, Nov 19, 2026: “Treatment-induced menopause linked to lasting vaginal changes”.

Exposure

38 papers study it14 findingsUpdated

7 new papers in 30 daysSee all 38 papers on endocrine therapy

At a glance

The findings reach people, from one lab or study. 9 independent labs in 6 countries.

“Treatment with chemotherapy, endocrine therapy, or radiotherapy was not associated with increased PD risk.”
Risk of Parkinson's Disease among Breast Cancer Survivors: A Nationwide Cohort Study in South KoreaCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2025doi:10.1158/1055-9965.epi-25-0712

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 9 independent labs in 6 countries
  • 1 finding against
  • Funders: National Institutes of Health and others
  • 1 of 11 findings with company ties
  • Humans24

What did studies of endocrine therapy find?

9

Studies of endocrine therapy measured 9 outcomes; the most studied is cognitive function (3 studies).

Cognitive function

downin humans2no changein humans1

3 studies
  1. Endocrine therapy is linked with worse cognitive function in humans (nonmetastatic breast cancer, across time).

    Humansnonmetastatic breast cancer, across time5-year follow-upfemales

  2. Endocrine therapy was not clearly linked with cognitive function in humans (early breast cancer).

    Humansearly breast cancer27 monthsfemalesn = 273

  3. Endocrine therapy impairs cognitive function in humans (breast cancer survivors; compared with breast cancer or healthy controls).

    Reviewbreast cancer survivors; compared with breast cancer or healthy controlsfemalesn = 2,398

Endometrial thickness

no changein humans1

1 study
  1. Endocrine therapy was not clearly linked with endometrial thickness in humans.

    Humansendometriumfemales

More on Endometrial thickness

Body weight

upin humans1

1 study
  1. Endocrine therapy is linked with higher body weight in humans.

    Humans

Bone mineral density

downin humans1

1 study
  1. Endocrine therapy decreases bone mineral density in breast cancer survivors.

    Reviewin breast cancer survivors

More on Bone mineral density

Parkinson's disease risk

no changein humans1

1 study
  1. Endocrine therapy was not clearly linked with parkinson's disease risk in humans (Breast cancer survivors).

    HumansBreast cancer survivorsfemales

Loss of chromosome Y

no changein humans1

1 study
  1. Endocrine therapy was not clearly linked with loss of chromosome Y in prostate cancer patients.

    Humansin prostate cancer patientsmalesn = 348

More on Loss of chromosome Y

Phenotypic Age Acceleration

upin humans1

1 study
  1. Endocrine therapy is linked with higher Phenotypic Age Acceleration in humans (10-year post-diagnosis vs surgery with or without radiotherapy) (ΔPAA=2.89, p=0.001).

    Humans10-year post-diagnosis vs surgery with or without radiotherapy

More on Phenotypic Age Acceleration

Leptin resistance

upin humans1

1 study
  1. Endocrine therapy increases leptin resistance in obese postmenopausal breast cancer patients.

    Reviewin obese postmenopausal breast cancer patients

Dementia incidence

no changein humans1

1 study
  1. Endocrine therapy was not clearly linked with dementia incidence in humans (Patients with breast cancer).

    HumansPatients with breast cancerfemales

What is endocrine therapy linked with?

3

Studies link endocrine therapy with 3 measures: endocrine and sexual dysfunction, urogenital symptoms and total Menopause Rating Scale score.

Endocrine and sexual dysfunction

upin humans1

1 study
  1. Endocrine therapy is associated with endocrine and sexual dysfunction in humans (breast cancer).

    Reviewbreast cancerfemales

More on Endocrine and sexual dysfunction

Urogenital symptoms

upin humans1

1 study
  1. Endocrine therapy is associated with urogenital symptoms in humans (DiD 0.71 points; 95% CI 0.26–1.16).

    HumansPostmenopausal women; difference-in-differences analysis using premenopausal women without breast cancer as the reference groupfemales

Total Menopause Rating Scale score

upin humans1

1 study
  1. Endocrine therapy is associated with total Menopause Rating Scale score in humans (Premenopausal women with breast cancer compared with women without breast cancer) (DiD 3.30 points; 95% CI 2.04–4.58 at 1 year).

    HumansPremenopausal women with breast cancer compared with women without breast cancer1 yearfemales

Funding

5 grants since 2019

National Cancer Institute$925KFonds Wetenschappelijk OnderzoekJapan Society for the Promotion of Science¥3.4M

Latest

Dec 2025: 2Jan 2026: 0Feb 2026: 2Mar 2026: 3Apr 2026: 0May 2026: 1Jun 2026: 2Jul 2026: 0Aug 2026: 0Sep 2026: 2Oct 2026: 4Nov 2026: 319 papers in 12 months
Research Square

Treatment-induced menopause linked to lasting vaginal changes

Vaginal health worsened within three months of menopause onset in women receiving breast cancer therapy; bacterial shifts persisted for up to 33 months.Vaginal health worsened within three months of menopause onset in women receiving breast cancer therapy; bacterial shifts persisted for up to 33 months.

Preprint: cohort · 60 peopleGenitourinary syndrome of menopause
medRxiv

No faster decline seen in women 75-plus with early breast cancer

An observational study followed 168 women with breast cancer and 336 without for 12 months, finding no significant differences in decline in daily functioning or thinking…An observational study followed 168 women with breast cancer and 336 without for 12 months, finding no significant differences in decline in daily functioning or thinking skills.

Preprint: cohort studyPopulations

See all 38 papers on endocrine therapy